Status:
COMPLETED
Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy
Lead Sponsor:
Università degli Studi di Brescia
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
Some studies have recently shown that the concentration of erythropoietin in the vitreous humor of diabetic patients suffering from diabetic retinopathy is higher than non-diabetic patients. It was re...
Eligibility Criteria
Inclusion
- CASE
- Inclusion criteria:
- type 2 diabetes,
- age greater than 18 years, and
- PDR.
- Exclusion criteria were:
- age less than 18 years,
- type 1 diabetes,
- initial DR,
- PDR patients not requiring surgery,
- previous vitrectomy in the eye under examination or other ophthalmic surgery or laser therapy within the previous 3 months.
- CONTROL
- Inclusion criteria:
- age greater than 18 years and the presence of macular pucker or macular hole requiring vitrectomy.
- Exclusion criteria were:
- age less than 18 years,
- diagnosis of diabetes mellitus, and
- previous vitrectomy in the eye under examination or other ophthalmic surgery or laser therapy within the previous 3 months.
Exclusion
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01871207
Start Date
May 1 2011
End Date
January 1 2012
Last Update
June 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Spedali Civili di Brescia
Brescia, Brescia, Italy, 25123